Penumbra Inc
(STU:0P8)
€
166.25
-0.75 (-0.45%)
Market Cap: 6.53 Bil
Enterprise Value: 6.43 Bil
PE Ratio: 551.91
PB Ratio: 6.28
GF Score: 86/100 Penumbra Inc at Citi Healthcare & Medtech Conference Transcript
Mar 02, 2023 / 04:00PM GMT
Release Date Price:
€242
(+0.83%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
So thank you, everybody, for coming back. We are now moving to the presentation for Penumbra. I'm thrilled that Jason Mills is here today. We also have Jee and the audience for other questions. So...
Jason Richard Mills
Penumbra, Inc. - EVP of Strategy
Thanks for having us.
Questions & Answers
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
I'm going to kick it off just with a big picture question. I mean, we've been following oh, man I've been following Penumbra for many years, but there's a lot going on this year. What is it that you want to make sure that investors hear in terms of how the year lays out and set expectations, both financially, but also from a product launch standpoint.
Jason Richard Mills
Penumbra, Inc. - EVP of Strategy
Well, I think what investors should hear is that we have a lot of patients that we need to help in our core markets. As you know, in the thrombectomy
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot